Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(1H-IMIDAZOL-1-YL)BENZOIC ACID, also known as 1-(3-CARBOXYBENZOYL)IMIDAZOLE, is a chemical compound with the molecular formula C10H8N2O2. It is a derivative of benzoic acid and contains an imidazole group. 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is recognized for its potential biological activity and is commonly utilized in pharmaceutical research and drug development. Its unique structure and properties have made it a subject of interest for the treatment of various diseases and conditions.

108035-47-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 108035-47-8 Structure
  • Basic information

    1. Product Name: 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID
    2. Synonyms: 3-IMIDAZOL-1-YL-BENZOIC ACID;3-(1H-IMIDAZOL-1-YL)BENZOIC ACID;3-(1H-Imidazol-1-yl)benzoic acid 97%;3-(1-IMidazolyl)benzoic Acid;1-(3-Carboxyphenyl)-1H-imidazole;3-(1H-Imidazol-1-yl)benzoicacid97%;3-(1-lmidazolyl)benzoic Acid
    3. CAS NO:108035-47-8
    4. Molecular Formula: C10H8N2O2
    5. Molecular Weight: 188.18
    6. EINECS: N/A
    7. Product Categories: Acids and Derivatives;Heterocycles
    8. Mol File: 108035-47-8.mol
  • Chemical Properties

    1. Melting Point: 194 °C
    2. Boiling Point: 427.6 °C at 760 mmHg
    3. Flash Point: 212.4 °C
    4. Appearance: white crystal powder
    5. Density: 1.28 g/cm3
    6. Vapor Pressure: 4.5E-08mmHg at 25°C
    7. Refractive Index: 1.631
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 3.78±0.10(Predicted)
    11. CAS DataBase Reference: 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID(CAS DataBase Reference)
    12. NIST Chemistry Reference: 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID(108035-47-8)
    13. EPA Substance Registry System: 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID(108035-47-8)
  • Safety Data

    1. Hazard Codes:  Harmful:;
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 108035-47-8(Hazardous Substances Data)

108035-47-8 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is used as a chemical intermediate for the synthesis of various pharmaceutical compounds due to its potential biological activity. It serves as a building block in the development of new drugs targeting a range of diseases and conditions.
Used in Cancer Treatment:
In the field of oncology, 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is used as a therapeutic agent for the treatment of various types of cancer. Its potential applications are being explored due to its ability to interact with biological targets, which may lead to the inhibition of cancer cell growth and proliferation.
Used in Inflammatory Disorder Management:
3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is also being investigated for its use in managing inflammatory disorders. Its potential to modulate inflammatory pathways makes it a candidate for the development of anti-inflammatory drugs.
Used in Antimicrobial Agent Development:
Given its antimicrobial properties, 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is used in the research and development of new antibiotics and antimicrobial agents. Its ability to combat microbial infections positions it as a valuable asset in the fight against antibiotic-resistant bacteria.
Used in Chemical Synthesis:
In the chemical industry, 3-(1H-IMIDAZOL-1-YL)BENZOIC ACID is used as a versatile reagent and intermediate in the synthesis of a variety of organic compounds, including those with potential applications in material science and other specialized fields.

Check Digit Verification of cas no

The CAS Registry Mumber 108035-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,0,3 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 108035-47:
(8*1)+(7*0)+(6*8)+(5*0)+(4*3)+(3*5)+(2*4)+(1*7)=98
98 % 10 = 8
So 108035-47-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H8N2O2/c13-10(14)8-2-1-3-9(6-8)12-5-4-11-7-12/h1-7H,(H,13,14)

108035-47-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1-Imidazolyl)benzoic Acid

1.2 Other means of identification

Product number -
Other names 3-(1H-Imidazol-1-yl)benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:108035-47-8 SDS

108035-47-8Relevant articles and documents

Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8

Kirsch, Philine,Jakob, Valentin,Oberhausen, Kevin,Stein, Saskia C.,Cucarro, Ivano,Schulz, Thomas F.,Empting, Martin

supporting information, (2019/05/01)

The latency-associated nuclear antigen (LANA) is required for latent replication and persistence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. It acts via replicating and tethering the virus episome to the host chromatin and exerts other functions. We conceived a new approach for the discovery of antiviral drugs to inhibit the interaction between LANA and the viral genome. We applied a biophysical screening cascade and identified the first LANA binders from small, structurally diverse compound libraries. Starting from a fragment-sized scaffold, we generated optimized hits via fragment growing using a dedicated fluorescence-polarization-based assay as the structure-activity-relationship driver. We improved compound potency to the double-digit micromolar range. Importantly, we qualified the resulting hit through orthogonal methods employing EMSA, STD-NMR, and MST methodologies. This optimized hit provides an ideal starting point for subsequent hit-to-lead campaigns providing evident target-binding, suitable ligand efficiencies, and favorable physicochemical properties.

Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8

Kirsch, Philine,Jakob, Valentin,Oberhausen, Kevin,Stein, Saskia C.,Cucarro, Ivano,Schulz, Thomas F.,Empting, Martin

supporting information, p. 3924 - 3939 (2019/05/06)

The latency-associated nuclear antigen (LANA) is required for latent replication and persistence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. It acts via replicating and tethering the virus episome to the host chromatin and exerts other functions. We conceived a new approach for the discovery of antiviral drugs to inhibit the interaction between LANA and the viral genome. We applied a biophysical screening cascade and identified the first LANA binders from small, structurally diverse compound libraries. Starting from a fragment-sized scaffold, we generated optimized hits via fragment growing using a dedicated fluorescence-polarization-based assay as the structure-activity-relationship driver. We improved compound potency to the double-digit micromolar range. Importantly, we qualified the resulting hit through orthogonal methods employing EMSA, STD-NMR, and MST methodologies. This optimized hit provides an ideal starting point for subsequent hit-to-lead campaigns providing evident target-binding, suitable ligand efficiencies, and favorable physicochemical properties.

Coordination polymers of various architectures built with mixed imidazole/benzimidazole and carboxylate donor ligands and different metal ions: Syntheses, structural features and magnetic properties

Aijaz, Arshad,Lama, Prem,Sanudo, E. Carolina,Mishra, Rupali,Bharadwaj, Parimal K.

experimental part, p. 2502 - 2514 (2011/01/11)

Ten coordination polymers {[Cd(L1)2]}n (1), {[Cu(L1)2]}n (2), {[Cd2(L 1)2(HCOO)2(H2O)]}n (3), {[Cd2(L1/sub

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 108035-47-8